ELITE Stock Overview
Provides diagnostic imaging services in Jamaica. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Elite Diagnostic Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JA$1.81 |
| 52 Week High | JA$2.62 |
| 52 Week Low | JA$1.25 |
| Beta | 0.12 |
| 11 Month Change | -24.27% |
| 3 Month Change | 16.77% |
| 1 Year Change | 5.85% |
| 33 Year Change | -43.44% |
| 5 Year Change | -65.85% |
| Change since IPO | -41.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| ELITE | JM Healthcare | JM Market | |
|---|---|---|---|
| 7D | -1.6% | -1.1% | 1.3% |
| 1Y | 5.8% | -2.7% | 5.7% |
Return vs Industry: ELITE exceeded the JM Healthcare industry which returned -2.7% over the past year.
Return vs Market: ELITE matched the JM Market which returned 5.7% over the past year.
Price Volatility
| ELITE volatility | |
|---|---|
| ELITE Average Weekly Movement | 14.2% |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in JM Market | 16.4% |
| 10% least volatile stocks in JM Market | 4.4% |
Stable Share Price: ELITE's share price has been volatile over the past 3 months compared to the JM market.
Volatility Over Time: ELITE's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of JM stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | Harvey Levers | elite-diagnostic.com |
Elite Diagnostic Limited provides diagnostic imaging services in Jamaica. The company offers CT scan, MRI, x-ray, ultrasound, and fluoroscopy services. It provides radiology procedures, including angiograms, catheter insertion, aspiration and biopsy, selective hysterosalpingogram and recanalization, lumbar puncture, sclerotherapy, and implant placement services.
Elite Diagnostic Limited Fundamentals Summary
| ELITE fundamental statistics | |
|---|---|
| Market cap | JA$639.65m |
| Earnings (TTM) | JA$20.19m |
| Revenue (TTM) | JA$827.93m |
31.7x
P/E Ratio0.8x
P/S RatioIs ELITE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ELITE income statement (TTM) | |
|---|---|
| Revenue | JA$827.93m |
| Cost of Revenue | JA$279.95m |
| Gross Profit | JA$547.98m |
| Other Expenses | JA$527.79m |
| Earnings | JA$20.19m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.057 |
| Gross Margin | 66.19% |
| Net Profit Margin | 2.44% |
| Debt/Equity Ratio | 68.6% |
How did ELITE perform over the long term?
See historical performance and comparison